Abstract bekijken

Deze abstract is toegekend aan sessies
TitelThe IOP lowering effect of combined iStent +phacoemulcification in patients with glaucoma: prospective study
DoelTo assess the IOP lowering effect of iStent insertion at the time of phacoemulsificationcombined in patients with glaucoma and to evaluate the number of topical medication needed to treat adequately the IOP, pre- and postoperatively.
MethodesProspective study. The first 100 patients who underwent a combined operation were included in this study. The IOP was measured on preop, D1, W1, M1, M3, M6, M12 and further. The number of topical medication was calculated, based on number of different therapeutical molecules.
ResultatenThe follow-up period was between 3 to 18 months. The IOP preop was 25.06 mmHg and postoperatively was 16.8 mmHg after 6 months. A mean reduction in the number of glaucoma medications per patient was 1.3, following iStent implant with phacoemulsification.
ConclusieCombined iStent + Phacoemulcification is an micro invasive surgery of the high IOP in patients with glaucoma and can be used as a definite or temporary treatment for these patients.
BelangenverstrengelingNee
Auteur 1
NaamHAAGDORENS
InitialenM
InstituutChirec Hospital Group, Delta site
StadBrussels
Auteur 2
NaamBOUSTANI
InitialenG
InstituutChirec Hospital Group, Delta site
StadBrussels
Auteur 3
NaamPOURJAVAN
InitialenS
InstituutChirec Hospital Group, Delta site
StadBrussels
top ^